Eli Lilly Valuation
| LLY Stock | USD 745.95 4.82 0.64% |
At this time, the firm appears to be fairly valued. Eli Lilly shows a prevailing Real Value of $731.56 per share. The current price of the firm is $745.95. Our model computes the value of Eli Lilly from reviewing the firm fundamentals such as Current Valuation of 695 B, shares outstanding of 950.77 M, and Profit Margin of 0.15 % as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Eli Lilly's valuation include:
Price Book 66.3424 | Enterprise Value 695 B | Enterprise Value Ebitda 86.0117 | Price Sales 20.9422 | Forward PE 60.241 |
Fairly Valued
Today
Please note that Eli Lilly's price fluctuation is very steady at this time. Calculation of the real value of Eli Lilly is based on 3 months time horizon. Increasing Eli Lilly's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Eli Lilly and is useful when determining the fair value of the Eli stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Eli Lilly. Since Eli Lilly is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eli Stock. However, Eli Lilly's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 745.95 | Real 731.56 | Target 603.57 | Hype 748.95 | Naive 718.75 |
The real value of Eli Stock, also known as its intrinsic value, is the underlying worth of Eli Lilly Company, which is reflected in its stock price. It is based on Eli Lilly's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Eli Lilly's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Eli Lilly's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Eli Lilly and helps investors to forecast how Eli stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eli Lilly more accurately as focusing exclusively on Eli Lilly's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Eli Lilly's intrinsic value based on its ongoing forecasts of Eli Lilly's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Eli Lilly's closest peers. When choosing an evaluation method for Eli Lilly, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Eli Lilly Investments |
|
Eli Valuation Trend
Knowing Eli Lilly's actual value is paramount for traders to make sound investment determinations. Eli Lilly's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Eli Lilly's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Eli Lilly's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Eli Market Cap
Eli Lilly and is currently regarded as number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 730.5 Billion. Eli Lilly totals roughly 709.22 Billion in market capitalization claiming about 97% of equities under Health Care industry.Eli Lilly Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Eli Lilly's current stock value. Our valuation model uses many indicators to compare Eli Lilly value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eli Lilly competition to find correlations between indicators driving Eli Lilly's intrinsic value. More Info.Eli Lilly and is rated second overall in price to earning category among related companies. It is currently regarded as number one stock in price to book category among related companies fabricating about 1.21 of Price To Book per Price To Earning. Price To Book Ratio is likely to rise to 51.15 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Eli Lilly by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eli Lilly's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eli Lilly's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Eli Lilly's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Eli Lilly and how it compares across the competition.
About Eli Lilly Valuation
The stock valuation mechanism determines the current worth of Eli Lilly and on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Eli Lilly and. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Eli Lilly based exclusively on its fundamental and basic technical indicators. By analyzing Eli Lilly's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Eli Lilly's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eli Lilly. We calculate exposure to Eli Lilly's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eli Lilly's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 27.5 B | 28.9 B | |
| Pretax Profit Margin | 0.19 | 0.25 | |
| Operating Profit Margin | 0.30 | 0.28 | |
| Net Profit Margin | 0.15 | 0.19 | |
| Gross Profit Margin | 0.81 | 0.62 |
Eli Lilly Quarterly Retained Earnings |
|
8 Steps to conduct Eli Lilly's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Eli Lilly's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Eli Lilly's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Eli Lilly's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Eli Lilly's revenue streams: Identify Eli Lilly's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Eli Lilly's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Eli Lilly's growth potential: Evaluate Eli Lilly's management, business model, and growth potential.
- Determine Eli Lilly's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Eli Lilly's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Eli Lilly represents a small ownership stake in the entity. As a stockholder of Eli, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Eli Lilly Dividends Analysis For Valuation
Dividend Payout Ratio is likely to rise to 0.82 in 2024, despite the fact that Dividends Paid is likely to grow to (3.9 B). . Price Earnings Ratio is likely to rise to 105.14 in 2024, whereas Retained Earnings are likely to drop slightly above 9.5 B in 2024.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -4.1 B | -3.9 B | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | 0.78 | 0.82 | |
| Dividend Paid And Capex Coverage Ratio | (1.28) | (1.21) |
There are various types of dividends Eli Lilly can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Eli shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Eli Lilly and directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Eli pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Eli Lilly by the value of the dividends paid out.
Eli Lilly Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Eli Lilly does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 903.3 M | |
| Quarterly Earnings Growth Y O Y | 0.13 | |
| Forward Price Earnings | 60.241 |
Eli Lilly Current Valuation Indicators
Valuation refers to the process of determining the present value of Eli Lilly and and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Eli we look at many different elements of the entity such as Eli's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Eli Lilly's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Eli Lilly's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Eli Lilly, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Eli Lilly's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Eli Lilly's worth.When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Eli Stock analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.13 | Dividend Share 4.52 | Earnings Share 5.78 | Revenue Per Share 37.908 | Quarterly Revenue Growth 0.281 |
The market value of Eli Lilly is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.